Product Images Sumatriptan Succinate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Sumatriptan Succinate NDC 55111-693 by Dr. Reddy's Laboratories Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

autoinjector - autoinjector

autoinjector - autoinjector

Sumatriptan Injection USP is a medication provided in a 6 mg/0.5 mL AUTOINJECTOR SYSTEM. The 15-injected-dose autoinjector is for subcutaneous injection only. The instruction to use the injector is provided in the text. The autoinjector is filled with a solution having 8 mg of sumatriptan succinate. The solution is sterile and pyrogenic and contains 3.5 mg of sodium chloride in 0 mL of the solution. The autoinjector should be stored between 15°C to 30°C. The manufacturer is Dr. Reddy's Laboratories Ltd in India.*

carton - carton

carton - carton

This is a set of instructions on how to use the Sumatriptan autoinjector system for a patient. The text describes step-by-step how to properly use the pen and inject the medication under the skin. The product comes with two autoinjectors containing 6mg of Sumatriptan injection, prescribing information, and instructions for use. There is additional information and details available at eyecom/products or Sumatriptan bk. The text was not utilized for any valuable comprehensive use.*

fig - fig

fig - fig

The text appears to be a diagram representing the estimated percentage of subjects with relief after taking placebo and Sumatriptan at different time intervals. The x-axis represents time in minutes and y-axis represents the percentage of subjects with relief. The estimated percentage of relief is indicated by the values 100%, 80%, 60%, and 10%. The diagram shows that Sumatriptan provides relief to a greater percentage of subjects compared to the placebo, starting at around 15 minutes after administration.*

fig1 - fig1

fig1 - fig1

fig10 - fig10

fig10 - fig10

fig11 - fig11

fig11 - fig11

fig2 - fig2

fig2 - fig2

fig3 - fig3

fig3 - fig3

fig4 - fig4

fig4 - fig4

fig5 - fig5

fig5 - fig5

fig6 - fig6

fig6 - fig6

fig7 - fig7

fig7 - fig7

fig8 - fig8

fig8 - fig8

fig9 - fig9

fig9 - fig9

stru - stru

stru - stru

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.